Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Vergès S, Lanier LL, Weisdorf D, Miller JS.

Blood. 2012 Mar 15;119(11):2665-74. doi: 10.1182/blood-2011-10-386995. Epub 2011 Dec 16.

2.

CMV induces rapid NK cell maturation in HSCT recipients.

Della Chiesa M, Muccio L, Moretta A.

Immunol Lett. 2013 Sep-Oct;155(1-2):11-3. doi: 10.1016/j.imlet.2013.09.020. Epub 2013 Sep 26. Review.

PMID:
24076315
3.

Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.

Muntasell A, Vilches C, Angulo A, López-Botet M.

Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117. Review.

4.

The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.

López-Botet M, Muntasell A, Vilches C.

Semin Immunol. 2014 Apr;26(2):145-51. doi: 10.1016/j.smim.2014.03.002. Epub 2014 Mar 22. Review.

PMID:
24666761
5.

Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections.

Della Chiesa M, Moretta L, Muccio L, Bertaina A, Moretta F, Locatelli F, Moretta A.

Curr Top Microbiol Immunol. 2016;395:209-24. doi: 10.1007/82_2015_450. Review.

PMID:
26160014
6.

The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Ciáurriz M, Zabalza A, Beloki L, Mansilla C, Pérez-Valderrama E, Lachén M, Bandrés E, Olavarría E, Ramírez N.

Cell Mol Life Sci. 2015 Nov;72(21):4049-62. doi: 10.1007/s00018-015-1986-z. Epub 2015 Jul 15. Review.

PMID:
26174234
7.

About Training and Memory: NK-Cell Adaptation to Viral Infections.

Hammer Q, Romagnani C.

Adv Immunol. 2017;133:171-207. doi: 10.1016/bs.ai.2016.10.001. Epub 2016 Nov 30. Review.

PMID:
28215279
8.

Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV.

Rölle A, Brodin P.

Trends Immunol. 2016 Mar;37(3):233-243. doi: 10.1016/j.it.2016.01.005. Epub 2016 Feb 9. Review.

PMID:
26869205
9.

Innate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function.

Lee SH, Webb JR, Vidal SM.

Microbes Infect. 2002 Dec;4(15):1491-503. Review.

PMID:
12505521
10.

The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses.

Pyzik M, Gendron-Pontbriand EM, Vidal SM.

J Biomed Biotechnol. 2011;2011:641702. doi: 10.1155/2011/641702. Epub 2011 May 22. Review.

11.

Development of the adaptive NK cell response to human cytomegalovirus in the context of aging.

López-Botet M, Muntasell A, Martínez-Rodríguez JE, López-Montañés M, Costa-García M, Pupuleku A.

Mech Ageing Dev. 2016 Sep;158:23-6. doi: 10.1016/j.mad.2016.06.010. Epub 2016 Jun 24. Review.

PMID:
27349430
12.

Impact of HCMV Infection on NK Cell Development and Function after HSCT.

Della Chiesa M, Falco M, Muccio L, Bertaina A, Locatelli F, Moretta A.

Front Immunol. 2013 Dec 13;4:458. doi: 10.3389/fimmu.2013.00458. Review.

13.

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?

Della Chiesa M, Sivori S, Carlomagno S, Moretta L, Moretta A.

Front Immunol. 2015 Nov 9;6:573. doi: 10.3389/fimmu.2015.00573. eCollection 2015. Review.

14.

Natural killer cell memory in context.

Holmes TD, Bryceson YT.

Semin Immunol. 2016 Aug;28(4):368-76. doi: 10.1016/j.smim.2016.05.008. Epub 2016 Jun 25. Review.

PMID:
27354353
15.

Natural Killer Cells in Human Immunodeficiency Virus-1 Infection: Spotlight on the Impact of Human Cytomegalovirus.

Peppa D.

Front Immunol. 2017 Oct 17;8:1322. doi: 10.3389/fimmu.2017.01322. eCollection 2017. Review.

16.

Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.

López-Botet M, Vilches C, Redondo-Pachón D, Muntasell A, Pupuleku A, Yélamos J, Pascual J, Crespo M.

Front Immunol. 2017 Feb 16;8:166. doi: 10.3389/fimmu.2017.00166. eCollection 2017. Review.

17.

Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression.

von Müller L, Mertens T.

Med Microbiol Immunol. 2008 Jun;197(2):75-82. doi: 10.1007/s00430-008-0087-0. Epub 2008 Mar 8. Review.

PMID:
18327609
18.

The Broad Spectrum of Human Natural Killer Cell Diversity.

Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA.

Immunity. 2017 Nov 21;47(5):820-833. doi: 10.1016/j.immuni.2017.10.008. Review.

PMID:
29166586
19.

Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.

Erlach KC, Böhm V, Knabe M, Deegen P, Reddehase MJ, Podlech J.

Med Microbiol Immunol. 2008 Jun;197(2):167-78. doi: 10.1007/s00430-008-0084-3. Epub 2008 Feb 29. Review.

PMID:
18309517
20.

NK cell interplay with cytomegaloviruses.

Lisnić B, Lisnić VJ, Jonjić S.

Curr Opin Virol. 2015 Dec;15:9-18. doi: 10.1016/j.coviro.2015.07.001. Epub 2015 Jul 21. Review.

PMID:
26208082

Supplemental Content

Support Center